ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells
Yimeng Wang, Zhenghao Li, Ziren Chen, Zhe Yu, Yue Zhang, Chao He, Ruiluan Chen, Yinan Huang, Hang Su, Jingfeng Zhou, Xinmin Fan, Zhiming Li, Yu J. Cao, Yun Chen, Lixin Wang, Zhenghong Lin, Yun Chen, Li Yu, Thomas J. Kipps, Suping Zhang Cancer Gene Therapy
· Springer Nature
· 2026-10-21
· DOI: 10.1038/s41417-026-01087-8
Аннотация
Cancer Gene Therapy, Published online: 21 October 2026; doi:10.1038/s41417-026-01087-8 ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells
Yimeng Wang, Zhenghao Li, Ziren Chen, Zhe Yu, Yue Zhang, Chao He et al. ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells. // Cancer Gene Therapy. – 2026. – DOI: 10.1038/s41417-026-01087-8. – URL: https://www.nature.com/articles/s41417-026-01087-8
Yimeng Wang, Zhenghao Li, Ziren Chen, Zhe Yu, Yue Zhang, Chao He, Ruiluan Chen, Yinan Huang, Hang Su, Jingfeng Zhou, Xinmin Fan, Zhiming Li, Yu J. Cao, Yun Chen, Lixin Wang, Zhenghong Lin, Yun Chen, Li Yu, Thomas J. Kipps, & Suping Zhang (2026). ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells. Cancer Gene Therapy. https://doi.org/10.1038/s41417-026-01087-8
Yimeng Wang, et al. “ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells.” Cancer Gene Therapy, 2026. doi:10.1038/s41417-026-01087-8.
@article{Wang2026,
title = {ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells},
author = {Wang, Yimeng and Li, Zhenghao and Chen, Ziren and Yu, Zhe and Zhang, Yue and He, Chao and Chen, Ruiluan and Huang, Yinan and Su, Hang and Zhou, Jingfeng and Fan, Xinmin and Li, Zhiming and Cao, Yu J. and Chen, Yun and Wang, Lixin and Lin, Zhenghong and Chen, Yun and Yu, Li and Kipps, Thomas J. and Zhang, Suping},
journal = {Cancer Gene Therapy},
year = {2026},
doi = {10.1038/s41417-026-01087-8},
url = {https://www.nature.com/articles/s41417-026-01087-8}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials